Effect of MTX Discontinuation on Shingrix Response in RA
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NCT06574594
- Lead Sponsor
- Konkuk University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Inclusion Criteria:<br><br> - fulfill 2010 ACR/EULAR classification criteria for rheumatoid arthritis<br><br> - age over 19 years<br><br> - methotrexate user<br><br> - agree for vaccination with shingrix<br><br>Exclusion Criteria:<br><br> - have other form of inflammatory arthritis or autoimmune-mediated disease<br><br> - malignancy, current infection, pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cell-mediated immunity (CD4+ and CD8+ T cell against herpes zoster)
- Secondary Outcome Measures
Name Time Method , Humoral immunity (anti-VZV antibody, anti-gE antibody)